Hot Stocks Buzz: Bank of America Corp (NYSE:BAC), Pfizer Inc. (NYSE:PFE)

On Wednesday, Shares of Bank of America Corp (NYSE:BAC), added 5.71 and closed at $17.97 in the last trading session. The last trading range of the stock ranges between $17.40 and $18.05. The company’s Market capitalization is $181.48 Billion with the total Outstanding Shares of 10.11 billion. Most wealthy individuals believe charitable giving (45 percent) and volunteering (31 percent) have the greatest potential for positive impact on society –far more so than voting for (13 percent) or contributing to (1 percent) a political candidate who shares their ideals on topics important to them – according to the 2016 U.S. Trust® Study of High Net Worth Philanthropy. Through an ongoing partnership with the Indiana University Lilly Family School of Philanthropy, the sixth in this series of biennial studies reveals a strong commitment to charitable causes among high net worth (HNW) households, and giving and volunteering levels poised to increase in future years:

Last year, the vast majority (91 percent) of HNW households donated to charity. This high rate of giving among the wealthy compares with 59 percent of the U.S. general population who donate to charity.1

Fifty percent of wealthy individuals volunteered their time and talents last year to charitable organizations they care about – twice the rate of the general population (25 percent).2

The study offers an optimistic view of future giving levels, with 83 percent of wealthy individuals planning to give as much (55 percent) or more (28 percent) in the next three years (through 2018) than they have in the past. Women, African Americans, and younger individuals (age 50 and under) are even more likely to increase their giving in the next three years.

Future levels of volunteerism are also promising. Among wealthy individuals who presently volunteer, 90 percent say they plan to do so as much (60 percent) or more (30 percent) over the next three years. Even among those who did not volunteer last year, 39 percent plan to do so during the coming years.

Technical Analysis: During the 52-week trading session the minimum price at which share price traded, registered at $10.91 and reached to max level of $18.05. The EPS of company is strolling at 1.35.

Shares of Pfizer Inc. (NYSE:PFE), jumped 7.07% and closed at $32.12 in the last trading session. The last trading range of the stock ranges between $31.05 and $33.37. The company’s Market capitalization is $192.39 Billion with the total Outstanding Shares of 6.07 billion. Pfizer Inc. (PFE) recently declared that the European Commission (EC) has approved IBRANCE® (palbociclib) for the treatment of women with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) locally advanced or metastatic breast cancer. The approval is for IBRANCE to be used in combination with an aromatase inhibitor. The approval also covers the use of IBRANCE in combination with fulvestrant in women who have received prior endocrine therapy.

IBRANCE is the first medicine to be approved in Europe that works by inhibiting cyclin-dependent kinases 4 and 6 (CDK 4/6). It also is the first new medicine approved for the treatment of women with this type of metastatic breast cancer in the first-line setting in nearly 10 years. Women with HR+/HER2- metastatic breast cancer represent about 60 percent of all metastatic breast cancer cases.1

“Recently’s approval of IBRANCE in the European Union (EU) brings an innovative and much-needed new treatment option to tens of thousands of women with HR+/HER2- metastatic breast cancer,” said Andreas Penk, M.D., regional president, International Developed Markets, Pfizer Oncology. “With strong and consistent data in three pivotal clinical studies and rapid adoption as a standard of care in the U.S., IBRANCE represents a potential new benchmark for the treatment of HR+/HER2- metastatic breast cancer in Europe.”

Technical Analysis: During the 52-week trading session the minimum price at which share price traded, registered at $28.25 and reached to max level of $37.39. The EPS of company is strolling at 1.00.

Leave a Reply

Your email address will not be published. Required fields are marked *